Spartina Biotechnologies: Funding, Investors & Team (Sep 2026)
An early-stage biotech startup called Spartina Biotechnologies is creating and using a platform (SIRENTM) for precisely delivering RNA molecules to particular cells and organs, starting with RNAi molecules to wipe out the SARS-CoV-2 virus genome. SIREN will naturally send natural-like RNA molecules to every organ that SARS-CoV-2 is capable of infecting and precisely destroy the virus's RNA without harming the RNA of any human genes, preventing the virus from replicating and spreading. Within a few months after discovery, the SIRENTM platform is prepared to quickly deploy to treat any new infection. By squelching harmful genes, SIRENTM can also treat a variety of human ailments, advancing the field of RNA therapies.
Spartina Biotechnologies has raised $200k across 1 funding round on record, the most recent an undisclosed round of $200k announced in Nov 2022.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Spartina Biotechnologies Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Spartina Biotechnologies Funding Rounds
Spartina Biotechnologies Founders and Leadership Team
Contact details for the Spartina Biotechnologies team: 1 of 1 has an email address on file.
Start 14-day free trial →Spartina Biotechnologies Funding Compared to Other Biotechnology Startups
Spartina Biotechnologies' latest round of $200k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Spartina Biotechnologies in Biotechnology and Santa Fe
Companies Similar to Spartina Biotechnologies
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
Shennon Biotechnologies conducts a thorough examination and control of an enormous quantity of cells,…
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
Spartina Biotechnologies Funding FAQs
What does Spartina Biotechnologies do?
An early-stage biotech startup called Spartina Biotechnologies is creating and using a platform (SIRENTM) for precisely delivering RNA molecules to particular cells and organs, starting with RNAi molecules to wipe out the SARS-CoV-2 virus genome. SIREN will naturally send natural-like RNA molecules to every organ that SARS-CoV-2 is capable of infecting and precisely destroy the virus's RNA without harming the RNA of any human genes, preventing the virus from replicating and spreading. Within a few months after discovery, the SIRENTM platform is prepared to quickly deploy to treat any new infection. By squelching harmful genes, SIRENTM can also treat a variety of human ailments, advancing the field of RNA therapies.
How much funding has Spartina Biotechnologies raised?
Spartina Biotechnologies has raised $200k across 1 round on record. The most recent is an undisclosed round of $200k announced in Nov 2022.
When did Spartina Biotechnologies last raise funding?
Spartina Biotechnologies' most recent funding round on record is an undisclosed round of $200k, announced in Nov 2022.
Who is the CEO of Spartina Biotechnologies?
Paul Laur is listed as CEO at Spartina Biotechnologies.
Where is Spartina Biotechnologies headquartered?
Spartina Biotechnologies is based in Santa Fe, New Mexico, United States.
How many employees does Spartina Biotechnologies have?
Spartina Biotechnologies is in the 1-10 employee band.
How does Spartina Biotechnologies' funding compare to other Biotechnology startups?
Spartina Biotechnologies' latest round of $200k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Spartina Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Spartina Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.